£59.99
£59.99
This book details a novel approach to controlling cancer with natural lignans. Instead of killing cancer cells, lignans redress malignancy by altering the tumor microenvironment to cut off its blood supply, effectively starving the cancer and leading to its gradual disappearance.
Cancer remains hardly curable by modern therapies. The author narrates his research and practice for curative therapies to control cancer using natural products such as lignans. Beginning with cancer cases of successful treatment, the author elaborates on why cancer may develop in some people but not in others, how cancer should be effectively treated, what lignans can do to cure cancer without causing detrimental reactions to the immune or other physiological functions, and how a person can effectively prevent cancer without having to suffer from so many uncomfortable prohibitions in daily life. The author emphasizes that lignans are not super killers to control cancer. Instead of killing cancer, lignans redress malignancy by ameliorating the gut microbiome and removing the tumor microenvironment. For instance, suppression of malignant angiogenesis minimizes blood supply to cancer and thus starves the cancer, leading to its gradual shrinkage and eventual disappearance via programmed cell death processes. Lignans strictly suppress malignant angiogenesis and other cancerous molecular events in the tumor microenvironment. This book is written for a broad range of readers, including biomedical professionals and those without a medical background, to learn about a novel dimension of effective cancer control.
This book uses solution-focused thinking to show how life with cancer may be lived well. Written in a chatty but powerfully effective style, it is for people who have cancer, their families, and friends, as well as the health professionals who seek to help them.
Public fear of breast cancer obscures the facts. Treatments can increase other health risks, while fear itself can impair quality of life. This book explores the history and mystery of breast cancer, from Ancient Egypt to the future, to champion the totality of women’s health.
This book highlights the usefulness of magnetic resonance imaging (MRI) for lung and thoracic tumors. Economical and with no radiation exposure, MRI offers advantages over CT and PET-CT, allowing for qualitative analysis of disease and early assessment of therapeutic effects.
The next generation of oncological hyperthermia selectively heats malignant cells. Due to its selectivity, this innovative concept is safer, less toxic, and uses significantly lower energy. This book shows the challenges, theoretical basis, and clinical results of the method.
As gynaecological cancer survival rates improve, quality of life after treatment is vital. This is the first textbook on managing the physical and psychological effects of treatment. It is essential reading for gynaecological oncology specialists and related disciplines.
This book provides a historical and applicable overview of current Interventional Oncology (IO) approaches. It explores treatment options, medical breakthroughs, and the disease processes themselves. This up-to-date review is crucial for learners and current interventionalists.
Learn how electrical pulses can make cancer treatment more efficient with fewer side effects. Successfully used with chemotherapy on over 3000 patients, this method doesn’t require high-tech resources, making it ideal for less-equipped healthcare settings.
This book describes the latest knowledge on hereditary colorectal cancer syndromes, focusing on management, surveillance, and screening. It discusses multidisciplinary care, risk estimation, genetic information, and future developments in this evolving field.
From a clinical pharmacist specializing in oncology, this book illuminates the fundamental aspects of solid and blood cancers and their novel drug therapies. Emphasizing key concepts, it provides a clear introduction for clinicians and students to understand oncology principles.
This volume covers cancer epidemiology, drug development, and therapies, presenting tools to assess side effects. It also explores patient quality of life, palliative care, and the global disparities that prevent equal access to diagnosis and treatment.
Mankind is in an arms race with drug-resistant pathogens. This book reveals how benign bacteria become pathogenic by acquiring new genes and proposes a third strategy beyond drugs and vaccines: achieving herd resistance by enhancing our protective intestinal microbiota.
Processing Your Order
Please wait while we securely process your order.
Do not refresh or leave this page.
You will be redirected shortly to a confirmation page with your order number.
